Skip to main content
. Author manuscript; available in PMC: 2020 May 16.
Published in final edited form as: Adv Funct Mater. 2019 Mar 27;29(20):1900018. doi: 10.1002/adfm.201900018

Figure 6. In vivo anticancer effect of siBCL2 LbL-NPs.

Figure 6.

Saline, CD44-targeted siBCL2 LbL-NPs or CD20/CD44-dual-targeted siBCL2 LbL-NPs were intravenously injected into SCID beige mice intravenously inoculated with firefly luciferase expressing Toledo cells. The saline and NPs were given twice in a week for 5 weeks from a week after inoculation of firefly luciferase expressing Toledo cells into the mice. (A) Luminescence images of Toledo cells in SCID beige mice. (B) Quantitative analyses of luminescence intensities from Toledo cells. Error represents SD of 5 biological replicates. P-values were determined by student’s t-test: ***, p ≤ 0.05; **, p ≤ 0.1; *, p ≤ 0.5.